Paul B Manning's most recent trade in Liquidia Corp was a trade of 18,396 Common Stock done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Liquidia Corp | Paul B. Manning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 18,396 | 38,755 (0%) | 0% | 0 | Common Stock | |
| Candel Therapeutics Inc | Paul B. Manning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Taysha Gene Therapies Inc | Paul B. Manning | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.75 per share. | 30 May 2025 | 750,000 | 2,841,704 | - | 2.8 | 2,062,500 | Common Stock |
| Candel Therapeutics Inc | Paul B. Manning | Director | Purchase of securities on an exchange or from another person at price $ 6.00 per share. | 16 Dec 2024 | 750,000 | 1,303,752 | - | 6 | 4,500,000 | Common Stock |
| Candel Therapeutics Inc | Paul B. Manning | Director | Purchase of securities on an exchange or from another person at price $ 6.00 per share. | 16 Dec 2024 | 500,000 | 1,142,406 | - | 6 | 3,000,000 | Common Stock |
| Verrica Pharmaceuticals Inc | Paul B. Manning | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2024 | 18,426,966 | 26,278,094 (101%) | 71% | - | Common Stock | |
| Verrica Pharmaceuticals Inc | Paul B. Manning | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2024 | 9,213,483 | 9,213,483 | - | - | Series A Warrants (right to buy) | |
| Verrica Pharmaceuticals Inc | Paul B. Manning | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2024 | 9,213,483 | 9,213,483 | - | - | Series B Warrants (right to buy) | |
| Verrica Pharmaceuticals Inc | Paul B. Manning | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2024 | 4,494,382 | 5,976,101 (23%) | 17% | - | Common Stock | |
| Verrica Pharmaceuticals Inc | Paul B. Manning | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2024 | 2,247,191 | 2,247,191 | - | - | Series B Warrants (right to buy) | |
| Verrica Pharmaceuticals Inc | Paul B. Manning | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2024 | 2,247,191 | 2,247,191 | - | - | Series A Warrants (right to buy) | |
| Verrica Pharmaceuticals Inc | Paul B. Manning | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Nov 2024 | 450,000 | 25,828,094 (100%) | 1% | 0 | Common Stock | |
| Verrica Pharmaceuticals Inc | Paul B. Manning | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Sep 2024 | 2,675,611 | 0 (0%) | 10% | 0 | Common Stock | |
| Verrica Pharmaceuticals Inc | Paul B. Manning | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Sep 2024 | 891,870 | 891,870 (3%) | 3% | 0 | Common Stock | |
| Verrica Pharmaceuticals Inc | Paul B. Manning | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Sep 2024 | 891,870 | 891,870 (3%) | 3% | 0 | Common Stock | |
| Verrica Pharmaceuticals Inc | Paul B. Manning | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Sep 2024 | 891,870 | 891,870 (3%) | 3% | 0 | Common Stock | |
| Liquidia Corp | Paul B. Manning | Director | Purchase of securities on an exchange or from another person at price $ 8.90 per share. | 12 Sep 2024 | 337,078 | 816,311 (2%) | 1% | 8.9 | 2,999,994 | Common Stock |
| Taysha Gene Therapies Inc | Paul B. Manning | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.25 per share. | 27 Jun 2024 | 1,333,333 | 1,333,333 | - | 2.2 | 2,999,999 | Common Stock |
| Candel Therapeutics Inc | Paul B. Manning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Liquidia Corp | Paul B. Manning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 20,359 | 299,689 (1%) | 0% | 0 | Common Stock | |
| Liquidia Corp | Manning Paul B. | Director | Purchase of securities on an exchange or from another person at price $ 7.16 per share. | 14 Dec 2023 | 279,330 | 279,330 (0%) | 0% | 7.2 | 2,000,003 | Common Stock |
| Taysha Gene Therapies Inc | Paul B. Manning | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.63 per share. | 17 Nov 2023 | 100,000 | 16,566,667 | - | 1.6 | 163,000 | Common Stock |
| Taysha Gene Therapies Inc | Paul B. Manning | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.90 per share. | 16 Aug 2023 | 16,466,667 | 16,466,667 | - | 0.9 | 14,820,000 | Common Stock |
| Verrica Pharmaceuticals Inc | Paul B. Manning | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.02 per share. | 24 Jul 2023 | 200,000 | 7,851,128 (30%) | 0% | 5.0 | 1,004,000 | Common Stock |
| Candel Therapeutics Inc | Paul B. Manning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Liquidia Corp | Paul B. Manning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2023 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Taysha Gene Therapies Inc | Paul B. Manning | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 31 Oct 2022 | 1,500,000 | 1,642,202 | - | 2 | 3,000,000 | Common Stock |
| Candel Therapeutics Inc | Paul B. Manning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2022 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Verrica Pharmaceuticals Inc | Paul B. Manning | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.10 per share. | 05 Jul 2022 | 4,761,904 | 13,651,128 (52%) | 18% | 2.1 | 9,999,998 | Common Stock |
| Liquidia Corp | Paul B. Manning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Taysha Gene Therapies Inc | Paul B. Manning | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 15,500 | 15,500 | - | - | Stock Option (right to buy) | |
| Liquidia Corp | Paul B. Manning | Director | Purchase of securities on an exchange or from another person at price $ 5.10 per share. | 18 Apr 2022 | 392,156 | 392,156 (1%) | 1% | 5.1 | 1,999,996 | Common Stock |
| Liquidia Corp | Paul B. Manning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 435,674 | 435,674 (1%) | 1% | 0 | Common Stock | |
| Taysha Gene Therapies Inc | Paul B. Manning | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.77 per share. | 02 Feb 2022 | 58,000 | 92,202 | - | 7.8 | 450,660 | Common Stock |
| Taysha Gene Therapies Inc | Paul B. Manning | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.84 per share. | 02 Feb 2022 | 50,000 | 142,202 | - | 7.8 | 392,000 | Common Stock |
| Taysha Gene Therapies Inc | Paul B. Manning | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.77 per share. | 02 Feb 2022 | 45,000 | 2,065,102 | - | 7.8 | 349,650 | Common Stock |
| Taysha Gene Therapies Inc | Paul B. Manning | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.84 per share. | 02 Feb 2022 | 26,602 | 2,091,704 | - | 7.8 | 208,560 | Common Stock |
| Taysha Gene Therapies Inc | Paul B. Manning | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.77 per share. | 02 Feb 2022 | 22,000 | 22,000 | - | 7.8 | 170,940 | Common Stock |
| Liquidia Corp | Paul B. Manning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Candel Therapeutics Inc | Paul B. Manning | Director, Ten Percent Owner | 29 Jul 2021 | 1,669,303 | 0 | - | - | Series B Preferred Stock | ||
| Candel Therapeutics Inc | Paul B. Manning | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 29 Jul 2021 | 1,625,000 | 1,681,000 | - | 8 | 13,000,000 | Common Stock |
| Candel Therapeutics Inc | Paul B. Manning | Director, Ten Percent Owner | 29 Jul 2021 | 1,361,069 | 0 | - | - | Series B Preferred Stock | ||
| Candel Therapeutics Inc | Paul B. Manning | Director, Ten Percent Owner | 29 Jul 2021 | 679,158 | 679,158 | - | - | Common Stock | ||
| Candel Therapeutics Inc | Paul B. Manning | Director, Ten Percent Owner | 29 Jul 2021 | 553,752 | 553,752 | - | - | Common Stock | ||
| Candel Therapeutics Inc | Paul B. Manning | Director | Purchase of securities on an exchange or from another person at price $ 7.36 per share. | 27 Jul 2021 | 36,000 | 36,000 | - | 7.4 | 264,834 | Common Stock |
| Candel Therapeutics Inc | Paul B. Manning | Director | Purchase of securities on an exchange or from another person at price $ 7.30 per share. | 27 Jul 2021 | 20,000 | 56,000 | - | 7.3 | 145,944 | Common Stock |
| Liquidia Corp | Paul B. Manning | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.52 per share. | 13 Apr 2021 | 198,413 | 737,646 (2%) | 0% | 2.5 | 500,001 | Common Stock |
| Liquidia Corp | Paul B. Manning | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 21,385 | 21,385 | - | - | Non-Qualified Stock Option (right to buy) |